Countries
Industry
Startup stage
Startup size
Funding
Impact startup SDGs
Showing: 2281 filtered startups

Aquaai

Aquaai is a marine robotics company that builds affordable robotic fish platforms or specialized fishlike Autonomous Underwater Vehicles (AUV) to collect and deliver real-time visual and environmental data that is accessible on an AI powered online dashboard for multiple industries. We currently service Norwegian sustainable salmon farms near the Arctic Circle.

Fixrate AS

Fixrate is a marketplace for large bank deposits. Our vision is to give banks and investors easier access to better terms. Our company was established in Steinkjer, Norway, in desember 2016. Our service was launched in oktober 2017. Currently eight people work in our company, and we have offices in Steinkjer, Trondheim and Oslo.Already over 7 bn NOK has been matches through our service, and we expect further growth in the coming months and years. We are a bunch working together towards a common goal - to make life easy for our customers! In our office you will find dedicated people who are self-driven and motivated, and who work in teams. Our team members are mainly experienced grown-up people.

Lifeness AS

Lifeness is an innovative health-tech company that is passionate about helping people live their healthiest lives. Our main focus is on physical, mental, and emotional well-being. We are dedicated to promoting Lifeness through an innovative digital platform that connects health professionals with patients, providing them with comprehensive and personalized digital treatment. We also offer fully digital therapeutics, also known as digital treatment. By leveraging Artificial Intelligence in various ways, we stay at the forefront of innovation. Our ultimate goal is to have a positive impact on global health, with a particular emphasis on addressing obesity, a leading cause of mortality worldwide. Our team members are located in different countries, but we share a common purpose - to improve the health and well-being of individuals worldwide. Together, we are fully committed to enhancing Lifeness for people everywhere.

Planck Technologies AS

We specialize in designing cutting-edge materials for energy storage applications. Our expertise lies in identifying the most promising materials that meet the specific requirements of energy storage use cases, and by leveraging advanced simulation techniques, such as computational chemistry and AI, we provide solutions that maximize performance, efficiency, and sustainability. With a focus on innovation and collaboration, we bridge the gap between material science and energy storage applications, enabling a cleaner, more efficient, and sustainable energy future. With a long experience from industry, we have strong focus on the problem, and on developing business models to commercialise these emerging technologies

Chooose

Chooose builds software to enable the lower carbon fuel value chain. Companies like Alaska Airlines, Air Canada, British Airways, Delta Air Lines, and Flexport use the Chooose platform to operate and scale their SAF programs and to advance voluntary and compliance carbon initiatives. With offices in Oslo and Miami, we are growing quickly and hiring for a variety of roles. Learn more and explore all of our open opportunities by visiting https://www.chooose.today.

W3schools Network AS

Do you want to create simplified and interactive learning experiences? Join us, on our mission here at W3schools. We believe that learning web development should be easy and available for everyone - everywhere! W3schools is an educational website that teaches coding for free and is a global leading web development platform. We have 65 million monthly visits and 2.75 billion yearly page views. Visit us: www.w3schools.com

Age Labs

Age Labs is a Norwegian molecular diagnostics company that discovers, develops and commercializes biomarkers for the early detection of age-related diseases. We offer a service for evaluating epigenetic drug effects for use in clinical trials. Our biomarker discovery pipeline includes a biological age predictor and a test predicting the severity of COVID-19 infection. To date, we have raised 30 MNOK in private and public funding, and became a Nordic Startup Awards finalist in 2020. We are supported by strong commercial and R&D partners, including Oslo University Hospital, the Norwegian Institute of Public Health, Merck Group and Fürst Medical Laboratory. Our mission is to develop novel precision biomarkers for the early detection of age related diseases to extend the human healthspan.

Vibelabs

We're builders who love teaching what we do. Vibelabs helps everyone become builders, teaching people with no coding experience how to build software and tools with AI. Nearly 1,000 people have gone through our programs, including teams from Telenor, OBOS, Mesta, and other leading Norwegian organizations. We partner with StartupLab to bring AI skills to corporate innovators and early-stage founders. But we don't just teach, we build. We launch our own ventures, and help founders, operators, and small teams turn ideas into real, scalable products. Combining AI-native workflows, rapid prototyping, and modern product thinking, we move fast without cutting corners. From early MVPs to production-ready platforms, we focus on execution, clarity, and momentum. The barrier to building software just dropped to near zero. Companies that get this will move faster. People who get this will have a massive edge. We're here to make sure as many as possible get there, practically, not theoretically.

Niuton AS

Niuton is a deep tech platform that works on autonomous and decentralized solutions based on Newtonian principles and our end customers are hedge funds. Currently, we have a team of five people, the tech dev and research stretches three years back and we have been with one year live with clients. Now we are looking for a senior python specialist to automate the data flow in and out of our core machinery. The data feed into Niutons machinery is from Twelvedata and the output is clients around the world. For the right candidate, we can consider offering 0.5% of shares equity (valuation right now 7.5 million USD), you will be assisted by our other senior python specialist that handles the core machinery itself. The expected duration of this assignment is three to four months ONLY. Start date 1. January 2022. Resources have to be available 100% of the time during the assignment, most preferably in Oslo. The MVP is ready, Niuton is now exactly what we want, and the success criterion is achieving 99% uptime on a day-to-day basis.

EedenBull AS

New technologies, new regulations, and new players are forever changing the way consumers AND businesses think about payments. At EedenBull we want to drive change and leverage the vast untapped opportunities that emerge from it. We are all about payments and to us, customer centricity is key. Our mission is to challenge the existing, aggressively look for weaknesses, seek to improve, and change the way people and businesses pay and get paid – anytime, anywhere.

Bergen Robotics

We are a team of dedicated scientists, engineers and designers with competence in computer vision, advanced robotics and edge AI. Bergen Robotics has developed an advanced autonomous payload for power-line inspections. The payload can shoot detailed images of specific components at high speed and fully based on onboard AI. The technology is now working and has found a new home at Haawk. AI. Bergen Robotics also own part of the med-tech company Flyt Medical AS and is responsible for technical development. Bergen Robotics can do consulting work provided that the work includes at least two of the following areas: - AI/Computer Vision - Robotics - Camera systems Send us a message or call for inquiries!

NEC OncoImmunity AS

OncoImmunity is a bioinformatics company providing unique machine-learning software to identify tumor-specific mutations that can be targeted by a patient’s own immune system (known as neoantigens). The OncoImmunity solution is important because recent breakthroughs in the field of Immuno-Oncology (I-O) such as the development of checkpoint inhibitors and personalized cancer vaccines, clearly demonstrate that a patient’s immune system can be harnessed to successfully treat cancer. The cost of identifying tumor-specific mutations in a patient’s cancer using next-generation sequencing (NGS) is now trivial and this technology will be key to enabling truly personalized immunotherapies to be developed in a technically and economically feasible manner. However, the remaining challenge that currently limits the field, and which is addressed by the OncoImmunity solution, is predicting which tumor-specific mutations can stimulate a patient’s immune system i.e. are immunogenic. Using NGS data as input, the OncoImmunity software enables accurate patient selection for cancer immunotherapy and can identify optimal targets for personalized cancer vaccines & cell therapies in a clinically actionable time frame. Beginning from this first product offering, OncoImmunity has the vision to become the world’s leading provider of software to guide cancer immunotherapy to improve survival rates for cancer patients. To achieve this OncoImmunity has assembled a growing team of world-class bioinformaticians, data scientists, and software engineers; developing its cutting-edge machine-learning technology that will help fulfill the promise of immunotherapy in the fight against cancer. OncoImmunity’s technology will disrupt the I-O field by offering regulatory-compliant prediction software on a software-as-a-service basis (SaaS). This will allow big pharma, biotechnology, and immunotherapy companies of any size to access OncoImmunity’s cutting-edge prediction software. The company is headquartered in an ideal scientific and entrepreneurial ecosystem to develop its technology at the Oslo Cancer Cluster Incubator; adjacent to the Institute for Cancer Research and the Norwegian Radium Hospital. OncoImmunity is a privately held company, founded in 2014 by experienced bioinformatics scientists (Dr. Trevor Clancy and Professor Eivind Hovig), and an experienced immunologist with a business development background (Dr. Richard Stratford). The company is backed by private financing from the Norwegian Radium Hospital Research Foundation, the Norwegian Cancer Society, STARTUPLAB, and Grotmol Solutions, in addition to a number of private software investors. The company is also supported by grants awarded from the Norwegian Research Council, Innovation Norway, and the EU. The company has already established both national and international collaborations and pilot projects to develop further proof-of-concept data and validate its software.

Dele Health Tech

Preventing One Million Falls Before 2024 Dele Health Tech is redefining how the market conceptualizes and achieves fall prevention by offering a data fusion platform that functions as middleware between hardware and data stream partners. Our mission: To save lives through fall prevention, and prevent one million falls by 2024.

Numus

Numus is developing a fintech platform to help banks and other financial institutions solve their problem of including and engaging new generation customers with the use of benchmarking and gamification. Numus is a personal finance and wealth management platform that aims to build trust and loyalty between Banks and their customers by providing tailored services and products to end-users and increase their engagement on their financial decisions.

Clikk

Clikk gives a home to all of your social media accounts and unites their content feeds. We are here to save you time, increase your visibility online and make sharing your social profiles easy and effortless. Discover new people, connect with them, and share your socials in one place! Let’s Clikk!